About Spectrum Oncology Private Limited
Data last updated: 26 July 2025
Spectrum Oncology Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Spectrum Pharmaceuticals Inc Usa. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 01 May 2008, the company has been in operation for over 18 years.
Registered with ROC Mumbai under CIN U51397MH2008PTC181835.
Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.9 Lakh. Formerly known as Oncorx Pharma Private Limited. It is led by directors including Arun Shankar Nanivadekar and Hemanshu Lalitbhai Kapadia.
Last AGM: 05 July 2023. Financial statements filed for year ended 31 March 2023. Office: Mumbai, Maharashtra.
As per the financials filed for FY 2023, the company reported a revenue of ₹3.91 Cr, a growth of 14% compared to the previous year.
It operates as a subsidiary of Spectrum Pharmaceuticals Inc Usa.
The company is associated with 1 brand - Spectrum Pharmaceuticals.
The company is currently under liquidation - its assets are being sold to settle outstanding debts. It may lack the legal capacity to fulfil new agreements, and creditors are prioritised in the distribution of proceeds. The last known website on record is sppirx.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressOfc No 1 Sadhana Bldg Gr Flr 207, David Barreto Rd Opp Wadala Stn Wadala West, Mumbai, Maharashtra, India – 400031
-
IndustryPharma, Pharma Contract R&D
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Spectrum Oncology Private Limited
Spectrum Oncology Private Limited operates one associated brand: Spectrum Pharmaceuticals. These brands represent Spectrum Oncology Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Small molecule therapeutics for oncology and hematology are developed. | sppirx.com |
Business Activity of Spectrum Oncology Private Limited
Spectrum Oncology Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details for Spectrum Oncology Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Spectrum Oncology Private Limited
Spectrum Oncology Private Limited is audited by GMJ & Co for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GMJ & Co | Locked | Locked | Locked |
Complete auditor history for Spectrum Oncology Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Spectrum Oncology Private Limited
Spectrum Oncology Private Limited is currently managed by 4 directors, with 16 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Shankar Nanivadekar | Director | 30 Jun 2009 | 17 Years 1 Months | As last reported |
|
Hemanshu Lalitbhai Kapadia
Also directs:
Perfunova (International) Limited, Integrated Pesticides Private Limited, Dnh And Dd Power Corporation Limited and 1 more
|
Irp/Rp/Liquidator | 09 May 2024 | 2 Years 3 Months | As last reported |
|
Purvish Mahendra Parikh
Also directs:
Medintel Services Private Limited
|
Director | 30 Jun 2009 | 17 Years 1 Months | As last reported |
|
Satyanarain Rameshwardas Agarwala
Also directs:
Blue Cross Laboratories Private Limited
|
Director | 01 May 2008 | 18 Years 3 Months | As last reported |
Financials of Spectrum Oncology Private Limited FY 2023 filings available
Spectrum Oncology Private Limited reported revenue of ₹3.91 Cr (up 14.00% YoY) for FY 2023.
Ten-year financial statements for Spectrum Oncology Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Spectrum Oncology Private Limited
Shareholding and ownership data for Spectrum Oncology Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings Spectrum Oncology Private Limited
Spectrum Oncology Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Spectrum Oncology Private Limited
View historical data on people associated with Spectrum Oncology Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Spectrum Oncology Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Spectrum Oncology Private Limited
GST registrations and filing compliance for Spectrum Oncology Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Spectrum Oncology Private Limited
Credit ratings, litigation, and regulatory alerts for Spectrum Oncology Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Spectrum Oncology Private Limited
MSME payment history for Spectrum Oncology Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Spectrum Oncology Private Limited
Corporate group structure for Spectrum Oncology Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Spectrum Oncology Private Limited
MCA filings and documents for Spectrum Oncology Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Spectrum Oncology Private Limited
Recent News on Spectrum Oncology Private Limited
Frequently Asked Questions about Spectrum Oncology Private Limited
Spectrum Oncology Private Limited is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Spectrum Oncology Private Limited is a company under liquidation, formerly operating as a private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 01 May 2008 and is registered under CIN U51397MH2008PTC181835. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Spectrum Oncology Private Limited reported revenue of ₹3.91 Cr for FY 2023 (up 14.00% YoY).
The current directors of Spectrum Oncology Private Limited are:
- Arun Shankar Nanivadekar - Director
- Hemanshu Lalitbhai Kapadia - Irp/Rp/Liquidator
- Purvish Mahendra Parikh - Director
- Satyanarain Rameshwardas Agarwala - Director
The CIN (Corporate Identification Number) of Spectrum Oncology Private Limited is U51397MH2008PTC181835. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The primary industry of Spectrum Oncology Private Limited is pharma. The company specifically operates in pharma contract r and d.